Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Cellular Dynamics International Unlocks the Potential of Banked Blood Samples

June 27, 2011 By Bio-Medicine.Org

MADISON, Wis., June 27, 2011 /PRNewswire/ — Cellular Dynamics
International (CDI) today announced the online publication of an
article in the journal Blood demonstrating for the first
time a methodology for researchers to access the biology stored in
repositories of banked blood samples through the creation of
induced pluripotent stem cells (iPSCs). According to the article,
entitled “Human lymphoblastoid B-cell lines reprogrammed to
EBV-free induced pluripotent stem cells,” the derived iPSCs
retained genotypic identity and were differentiated into cell types
comprising all three germ layers in the body, including blood,
heart, neural, and liver cells.

Blood samples are often banked as reference material from the
study of various diseases, rare genetic disorders and genome wide
association studies (GWAS). To bank these blood lines, they are
genetically modified through the introduction of Epstein-Barr virus
(EBV) to enable them to be frozen, thawed and proliferate
indefinitely, known as “immortalization.” This Blood paper
describes the ability to take small volumes of EBV-transformed
blood and create induced pluripotent stem cells (iPSCs), as well as
terminally differentiated somatic cells, that do not contain the
EBV genetic modification.

“CDI’s published methodology enables the unprecedented
opportunity to take samples from disease cohort repositories
worldwide, where blood has been collected and immortalized from
patients with a wide variety of diseases and known genotypic and
phenotypic backgrounds, and create iPSC-based human cellular models
for disease research and drug discovery,” said Nick Seay, CDI Chief
Technology Officer and an author of the paper.  “Our ability
to take samples of banked blood and create EBV-free iPSCs, and use
that material to manufacture cells in the quantity, quality and
purity required for research, is an important step forward in the
study of human biology and understanding the promise of
regene

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech